Skip to main content

Table 1 Patients characteristics

From: Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme

Variables

No

%

Age at diagnosis

  

Median

53 years

 

Range

22 - 73 years

 

Gender

  

Male

14

56

Female

11

44

RPA class

  

III

4

16

IV

13

52

V

8

32

KPS

  

70

9

36

80

7

28

90

6

24

100

3

12

Lobe involved

  

Cortical

23

92

Central (pineal, cerebellum)

2

8

Type of surgery

  

Gross total resection

3

12

Subtotal resection

12

52

Biopsy only

9

36

Concomitant TMZ

  

Yes

25

100

No

0

0

Adjuvant TMZ

  

Yes

19

76

No

6

24

Patients who completed >2 cycles

12

48

  1. Abbreviations: RPA: recursive partitioning analysis; KPS: Karnofsky perfomans status; TMZ: Temozolamide.